Comparing Dakota Gold (NYSE:DC) & Lexaria Bioscience (OTCMKTS:LXRP)

Dakota Gold (NYSE:DC) and Lexaria Bioscience (OTCMKTS:LXRP) are both small-cap basic materials companies, but which is the better business? We will compare the two businesses based on the strength of their earnings, valuation, dividends, profitability, analyst recommendations, institutional ownership and risk.

Profitability

This table compares Dakota Gold and Lexaria Bioscience’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Dakota Gold	N/A	-37.64%	-35.60%
Lexaria Bioscience	-1,046.77%	-157.62%	-148.09%

Valuation and Earnings

This table compares Dakota Gold and Lexaria Bioscience”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Dakota Gold	N/A	N/A	-$36.45 million	($0.27)	-14.81
Lexaria Bioscience	$380,000.00	0.00	-$4.09 million	N/A	N/A

Lexaria Bioscience has higher revenue and earnings than Dakota Gold.

Institutional & Insider Ownership

37.4% of Dakota Gold shares are held by institutional investors. Comparatively, 0.1% of Lexaria Bioscience shares are held by institutional investors. 17.4% of Dakota Gold shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Analyst Ratings

This is a summary of current ratings and price targets for Dakota Gold and Lexaria Bioscience, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Dakota Gold	0	0	1	0	3.00
Lexaria Bioscience	0	0	0	0	0.00

Dakota Gold currently has a consensus target price of $10.50, suggesting a potential upside of 162.50%. Given Dakota Gold’s stronger consensus rating and higher possible upside, equities analysts plainly believe Dakota Gold is more favorable than Lexaria Bioscience.

Summary

Dakota Gold beats Lexaria Bioscience on 8 of the 10 factors compared between the two stocks.

About Dakota Gold

Dakota Gold Corp. engages in the acquisition, exploration, and development of mineral properties in the United States. It primarily explores for gold deposits. The company holds 100% interest in the Blind Gold, City Creek, Tinton, West Corridor, Ragged Top, Poorman Anticline, Maitland, South Lead/ Whistler Gulch, the Barrick Option, Richmond Hill and Homestake Paleoplacer Properties located in Homestake Mining District, South Dakota. Dakota Gold Corp. was incorporated in 2017 and is based in Lead, South Dakota.

About Lexaria Bioscience

Lexaria Bioscience Corp. operates in the drug delivery platform business. It develops and out-licenses its DehydraTECH technology for the delivery of bioactive compounds that promotes healthy ingestion methods, lower overall dosing, and higher effectiveness in active molecule delivery. The company has licensed DehydraTECH to various companies operating in the nicotine, pharmaceutical, nutraceutical, and vitamin industries. Lexaria Bioscience Corp. was founded in 2004 and is headquartered in Kelowna, Canada.